Swiss National Bank decreased its holdings in Integer Holdings Corporation (NYSE:ITGR – Free Report) by 1.2% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 64,200 shares of the medical equipment provider’s stock after selling 800 shares during the quarter. Swiss National Bank owned 0.18% of Integer worth $7,895,000 as of its most recent SEC filing.
Other institutional investors and hedge funds also recently modified their holdings of the company. SVB Wealth LLC purchased a new stake in shares of Integer during the first quarter valued at $35,000. CWM LLC increased its position in shares of Integer by 46.1% in the second quarter. CWM LLC now owns 355 shares of the medical equipment provider’s stock worth $44,000 after acquiring an additional 112 shares in the last quarter. GAMMA Investing LLC raised its holdings in shares of Integer by 20.2% during the second quarter. GAMMA Investing LLC now owns 796 shares of the medical equipment provider’s stock valued at $98,000 after acquiring an additional 134 shares during the period. Headlands Technologies LLC lifted its position in shares of Integer by 1,234.8% in the 1st quarter. Headlands Technologies LLC now owns 1,228 shares of the medical equipment provider’s stock valued at $145,000 after acquiring an additional 1,136 shares in the last quarter. Finally, Quantbot Technologies LP acquired a new position in Integer in the 1st quarter worth approximately $193,000. Institutional investors and hedge funds own 99.29% of the company’s stock.
Insider Activity
In other Integer news, EVP Diron Smith acquired 1,116 shares of the company’s stock in a transaction dated Friday, November 7th. The shares were acquired at an average cost of $67.19 per share, for a total transaction of $74,984.04. Following the completion of the purchase, the executive vice president owned 7,698 shares of the company’s stock, valued at approximately $517,228.62. This trade represents a 16.96% increase in their position. The purchase was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CEO Payman Khales bought 3,127 shares of the firm’s stock in a transaction that occurred on Thursday, October 30th. The shares were acquired at an average price of $64.94 per share, with a total value of $203,067.38. Following the purchase, the chief executive officer owned 22,865 shares in the company, valued at $1,484,853.10. This trade represents a 15.84% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders acquired a total of 5,843 shares of company stock valued at $384,771 in the last quarter. 2.16% of the stock is currently owned by corporate insiders.
Wall Street Analyst Weigh In
View Our Latest Analysis on Integer
Integer Trading Up 0.2%
Shares of NYSE:ITGR opened at $72.18 on Friday. The company has a current ratio of 3.71, a quick ratio of 2.45 and a debt-to-equity ratio of 0.70. The stock has a market capitalization of $2.53 billion, a PE ratio of 30.20, a P/E/G ratio of 0.60 and a beta of 0.95. Integer Holdings Corporation has a 1 year low of $62.00 and a 1 year high of $146.36. The firm has a fifty day moving average price of $85.05 and a 200 day moving average price of $103.53.
Integer (NYSE:ITGR – Get Free Report) last released its quarterly earnings results on Thursday, October 23rd. The medical equipment provider reported $1.79 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.68 by $0.11. Integer had a return on equity of 12.84% and a net margin of 4.75%.During the same quarter in the prior year, the firm posted $1.43 earnings per share. The business’s quarterly revenue was up 8.4% on a year-over-year basis. Integer has set its FY 2025 guidance at 6.290-6.430 EPS. Analysts expect that Integer Holdings Corporation will post 6.01 EPS for the current fiscal year.
Integer declared that its Board of Directors has approved a share repurchase program on Tuesday, November 4th that allows the company to buyback $200.00 million in shares. This buyback authorization allows the medical equipment provider to repurchase up to 8.3% of its stock through open market purchases. Stock buyback programs are usually an indication that the company’s leadership believes its shares are undervalued.
Integer Company Profile
Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.
Featured Stories
- Five stocks we like better than Integer
- P/E Ratio Calculation: How to Assess Stocks
- Meta Platforms May Ditch NVIDIA Chips—Here’s Why Investors Care
- Which Wall Street Analysts are the Most Accurate?
- SoFi Technologies: From Fintech Speculation to Profit Engine
- Top Biotech Stocks: Exploring Innovation Opportunities
- Gold to $5,000? What Bank of America and UBS Have to Say
Want to see what other hedge funds are holding ITGR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Integer Holdings Corporation (NYSE:ITGR – Free Report).
Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.
